跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 84 条关于
“MannKind”
全部
84
临床试验
46
药物
13
机构
3
资讯
22
去年
MannKind Acquires scPharmaceuticals for Up to $360M to Expand Cardiorenal Portfolio
去年
MannKind Secures $500 Million Strategic Financing from Blackstone to Advance Inhaled Therapeutics Pipeline
去年
MannKind Prepares to Present Pediatric Inhaled Insulin Data at ADA Scientific Sessions
去年
MannKind and United Therapeutics Expand Partnership for Second Pulmonary Hypertension Inhaled Therapy
11个月前
MannKind Appoints Dr. Ajay Ahuja as Chief Medical Officer to Advance Inhaled Therapeutics Pipeline
3个月前
MannKind Corporation Receives FDA Approval for Afrezza Inhaled Insulin in Pediatric Diabetes Patients
10个月前
MannKind Discontinues Phase 3 Trial of Nebulized Clofazimine for NTM Lung Disease Due to Futility
9个月前
FDA Accepts MannKind's ReadyFlow Autoinjector Application for Rapid Furosemide Delivery in Heart Failure
2年前
MannKind's Clofazimine Inhalation Suspension Phase 3 Trial for NTM Lung Disease Cleared in Japan
去年
MannKind Initiates Phase 3 Trial of Clofazimine Inhalation Suspension for NTM Lung Disease
第 1 页,共 3 页
上一页
下一页